BONK, INC. current report, 17 July 2023

Business Context and Reporting Period

This Form 8-K was filed by Jupiter Wellness, Inc., not BONK, INC. The report concerns events beginning July 17, 2023, with the filing signed July 20, 2023. Jupiter Wellness is a Delaware company whose common stock trades under JUPW and warrants under JUPWW on Nasdaq.

Material Corporate Event

On July 17, 2023, the board appointed John Gulyas as a director. Gulyas was the founder and president of GBB Drink Lab, which the company stated it had recently acquired, and has experience operating franchise and consumer businesses.

  • Annual director compensation: $25,000.
  • Equity compensation: options to purchase 50,000 common shares for each year of board service.
  • Exercise price: the market price of the common stock at issuance.
  • Option term: three years from issuance, subject to the applicable stock award agreement.

Financial Metrics and Liquidity

The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, balance-sheet, or other operating financial metrics. It is an event-driven filing and does not present a comparable prior-period analysis.

Guidance, Outlook, Risks, and Unusual Items

The filing does not provide formal financial guidance or an operating outlook. The principal unusual item is the appointment of a director associated with GBB Drink Lab and the related compensation and potential equity dilution.

The company stated that there were no reportable related-party transactions under Item 404(a) of Regulation S-K, no family relationships involving the appointee and other company officials, and no other arrangements or understandings related to the appointment.

Key Facts to Verify

  • Confirm the correct registrant: the supplied filing identifies Jupiter Wellness, Inc., whereas the request metadata identifies BONK, INC.
  • Review Exhibit 10.1 for the complete employment agreement and the precise vesting and award terms.
  • Verify the actual option issuance date, exercise price, vesting conditions, and resulting potential dilution.
  • Review the referenced press release and acquisition disclosures concerning GBB Drink Lab.
  • Reconcile the report date of July 17, the agreement date of July 18 stated in Exhibit 10.1, and the press-release and signature dates of July 20.